Corporate insider profile
John R Stuelpnagel Insider Trades
Latest reported as Director of 10x Genomics, Inc. (TXG).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$2,390,128.00
- Latest transaction
- Sep 3, 2026
Transaction history
Corporate insider profile
Latest reported as Director of 10x Genomics, Inc. (TXG).
Transaction history